Ethicon Transvaginal Mesh Lawsuit [2026 Update]

Ethicon Transvaginal Mesh Lawsuit Overview

Ethicon became a central target in national litigation involving vaginal and pelvic mesh products implanted to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP).

Many of these transvaginal mesh cases focused on devices made with polypropylene mesh, which was intended to reinforce weakened pelvic support structures.

Plaintiffs in the vaginal mesh case against Ethicon commonly alleged that this material could interact poorly with vaginal tissue over time, contributing to inflammation, erosion or exposure, pain, and other complications.

Reported vaginal mesh injuries often included chronic pelvic pain, painful intercourse, infections, urinary problems, bleeding, scarring, and repeat surgeries intended to revise or remove implanted mesh.

Because symptoms can emerge gradually, many claims turned on medical documentation that showed how complications developed, how the device was identified, and what treatment was required.

Ethicon was named in federal multidistrict litigation (MDL) proceedings that coordinated many of these cases in one court for pretrial management.

That MDL is now terminated, but lawyers are still investigating individual cases against the company because the injuries and alleged failure-to-warn or design issues can remain fact-intensive long after implantation.

For many patients, the key question is whether the records show a specific Ethicon device and a complication pattern consistent with the injuries described in prior litigation.

Developments in vaginal mesh lawsuits against Ethicon:

• Ethicon pelvic mesh lawsuits were centralized in federal multidistrict litigation (MDL No. 2327) in the Southern District of West Virginia to coordinate pretrial proceedings across many filed claims.
• The FDA’s long-running oversight of urogynecologic mesh, including major safety communications and evolving evidentiary demands, shaped how transvaginal prolapse mesh was evaluated by regulators and litigants.
• On April 16, 2019, the FDA ordered remaining manufacturers to stop selling and distributing transvaginal mesh products for POP repair in the United States, a major turning point in the broader mesh landscape.
• The court’s MDL docket information reflects that MDL 2327 was ultimately closed and terminated (March 19, 2021).
• Separate from MDL administration, reported trial outcomes and public reporting on Ethicon-related cases contributed to ongoing attention to device-specific allegations and claimed injury mechanisms.

For someone evaluating a potential claim today, the most important starting point is identifying which vaginal and pelvic mesh products were implanted and why, since SUI and POP procedures are not always discussed the same way in records.

A case review typically focuses on operative notes, implant stickers, and subsequent treatment records that document the course of symptoms and any corrective procedures.

Even without an active MDL, transvaginal mesh cases can still be pursued individually when the facts support allegations tied to a particular product, implantation history, and injury pattern.

These evaluations often center on how the mesh behaved in vaginal tissue, the seriousness of the resulting complications, and the extent of medical treatment required.

Ethicon Vaginal Mesh Products Named in Lawsuits

Ethicon was one of the most prominent vaginal mesh manufacturers named in nationwide litigation involving pelvic repair devices.

Claims involving Ethicon vaginal mesh devices often focus on specific product lines used in procedures for pelvic organ prolapse or stress urinary incontinence.

Patients may not recognize the product name at the time of surgery, since operative notes and billing records often use shorthand terms or brand families rather than full device identifiers.

Ethicon products commonly named in lawsuits include:

• Gynecare Prolift
• Gynecare Prolift+M
• Gynecare Prosima
• Gynecare TVT
• Gynecare TVT-O
• Gynecare TVT Secu

Injuries and Complications Linked to Transvaginal Mesh

Transvaginal mesh injuries and complications are a central issue in litigation involving pelvic repair implants placed through the vagina.

Many lawsuits against transvaginal mesh manufacturers allege that certain surgical mesh devices were prone to erosion, contraction, or migration once implanted, especially in the delicate anatomy of the pelvic floor.

When mesh is implanted through or near the vaginal wall, patients may experience symptoms that worsen over time rather than resolve after recovery from mesh implant surgeries.

Some complications present as localized tissue damage, while others involve broader pelvic dysfunction that affects urination, mobility, and sexual function.

In more serious cases, the complication is not just discomfort, but severe injuries that require additional operations and long-term medical care.

Commonly reported injuries and complications include:

• Chronic pain in the pelvis, groin, or lower back
• Mesh erosion or exposure through the vaginal wall
• Infection, inflammation, and persistent discharge or bleeding
• Pain during sex (dyspareunia) and reduced sexual function
• Urinary problems, including urgency, retention, or recurrent UTIs
• Nerve irritation, burning sensations, or radiating pain
• Scarring and mesh contraction or shrinkage
• Organ perforation or injury during implantation or revision procedures
• Need for revision surgery, partial excision, or attempted mesh removal

Mesh removal can be medically complicated because implanted material may integrate into tissue and scar planes, making complete excision difficult in some cases.

Even after revision procedures, patients may continue to deal with chronic pain or functional symptoms that require ongoing treatment.

These outcomes are why device identification and a clear timeline of symptoms and medical interventions often matter in evaluating potential claims.

How are Vaginal Mesh Injuries and Complications Typically Treated?

Treatment for injuries linked to defective pelvic mesh and transvaginal mesh depends on the type of complication, how long the mesh has been implanted, and how the surrounding tissue has responded.

Some transvaginal mesh complications can initially be managed conservatively, but symptoms often progress when mesh has eroded into or adhered to tissue.

When mesh integrates into weakened vaginal walls, treatment becomes more complex and may require surgical intervention by specialists familiar with mesh-related injuries.

In many cases, patients undergo additional procedures following the original transvaginal mesh implant, especially when pain, erosion, or organ involvement persists.

Treatment approaches may include:

• Pain management through medication, physical therapy, or nerve-targeted care
• Treatment of infections or inflammation linked to exposed or eroded mesh
• Partial excision during transvaginal mesh surgery to remove exposed or problematic sections
• Complete or near-complete mesh removal when feasible, often requiring multiple surgeries
• Follow-up care and reconstruction after multiple revision surgeries, depending on tissue damage and symptom severity

FDA Actions and Oversight of Vaginal Mesh

The FDA’s oversight of vaginal mesh evolved in stages, with the agency drawing sharper distinctions over time between mesh used for pelvic organ prolapse (POP) repair through the vagina and mesh used for stress urinary incontinence (SUI) procedures.

In 2008, the FDA issued a Public Health Notification about complications associated with transvaginal placement of surgical mesh for POP and SUI, then revisited the issue as adverse event reports and published data grew.

After reviewing available evidence, the FDA’s 2011 Safety Communication stated that serious complications associated with transvaginal POP mesh are not rare, and it questioned whether transvaginal POP repair with mesh improved outcomes compared to traditional non-mesh repairs in all patients.

In January 2012, the FDA ordered manufacturers to conduct 522 postmarket surveillance studies for certain urogynecologic mesh devices, including mesh used for transvaginal POP repair and mini-slings for SUI, to address specific safety and effectiveness questions.

By April 16, 2019, after reviewing premarket approval applications, the FDA ordered remaining manufacturers of transvaginal mesh for POP repair to stop selling and distributing those products in the United States.

The FDA’s stated rationale focused on the absence of evidence demonstrating a reasonable assurance of safety and effectiveness, including the agency’s view that the submitted data did not meet the evidentiary expectations discussed by an FDA advisory panel earlier that year.

The FDA has continued to address SUI slings and abdominal POP mesh procedures separately from transvaginal POP mesh kits.

These actions did not declare that every mesh implant or every patient outcome would be the same, but they did raise the bar for what manufacturers had to prove, especially for transvaginal POP mesh.

Do You Qualify for the Ethicon Transvaginal Mesh Lawsuit?

Eligibility for Ethicon transvaginal mesh litigation usually starts with proof that an Ethicon pelvic mesh device was implanted during a procedure for pelvic organ prolapse or stress urinary incontinence.

Many vaginal mesh claims also depend on documented symptoms or treatment showing that the patient experienced meaningful harm after implantation.

Common pelvic mesh complications that may support a case include mesh erosion or exposure, chronic pelvic pain, infection, urinary problems, painful intercourse, or the need for revision surgery or removal attempts.

A qualifying case typically involves a clear timeline that connects the onset or progression of symptoms to the mesh implant and subsequent medical care.

Because medical charts do not always list a brand name in plain language, operative reports, implant stickers, and revision records often become critical for confirming the product and procedure.

Prior case history matters, but each claim still turns on individual facts such as the device used, the injury pattern, and the treatment required.

Although large proceedings have ended, vaginal mesh lawsuits continue to be filed individually in appropriate courts, and case screening still focuses on evidence and deadlines.

Anyone considering vaginal mesh litigation should treat the statute of limitations as case-specific, since many states use discovery rules that can depend on when the injury was identified or reasonably linked to the mesh.

Gathering Evidence for a Vaginal Mesh Implant Lawsuit

Evidence is often the difference between a vague suspicion and a viable vaginal or pelvic mesh case, because the claim usually depends on proving what device was implanted, what went wrong, and what treatment was required.

Lawyers typically start by building a complete medical timeline that connects the mesh implant to the onset of symptoms, the progression of complications, and any corrective care.

That record-building also helps frame how a case may involve alleged design and manufacturing defects, inadequate warnings, or both, depending on the product and injury pattern.

Because hospitals and surgeons do not keep every record forever, attorneys also focus on preserving time-sensitive materials, especially when a patient has undergone or may need mesh removal surgeries.

Once gathered, evidence has to be organized in a way that supports medical causation, damages, and product identification, which is why experienced case teams spend significant time on retrieval, indexing, and expert-ready documentation.

Evidence often includes:

• Operative reports from the original implant procedure
• Implant stickers, device labels, or product lot numbers from the hospital chart
• Medical records documenting symptoms, follow-up visits, and complication diagnoses
• Imaging and diagnostic testing related to pelvic pain, urinary issues, or erosion
• Records from revision procedures and mesh removal surgeries, including pathology when available
• Pharmacy and treatment records tied to infection, chronic pain, or nerve symptoms
• Physical therapy and pelvic floor therapy records
• Photos or clinical notes documenting vaginal wall erosion or mesh exposure
• Employment and wage records if complications affected work capacity
• A written symptom timeline describing onset, progression, and day-to-day limitations

Damages in Vaginal Mesh Lawsuits

Damages in vaginal mesh lawsuits refer to the losses a patient can document and tie to the injury, including medical, financial, and quality-of-life harms.

Vaginal mesh lawyers typically evaluate damages by collecting records, building a treatment timeline, and identifying how complications changed the person’s daily life and future care needs.

They also use billing records, expert input, and employment documentation to quantify costs that are already known and project costs that are reasonably expected.

While transvaginal mesh settlements and verdicts vary widely, damages analysis focuses on the specific facts of the case, not headline numbers from other lawsuits.

The goal is to present a grounded, evidence-based valuation that reflects the seriousness of the injury and the long-term impact on health and functioning.

Damages commonly claimed include:

• Past and future medical expenses related to treatment, revision care, and ongoing monitoring
• Costs tied to pain management, pelvic floor therapy, and prescription medications
• Lost wages and reduced earning capacity due to time away from work or lasting limitations
• Physical pain and suffering, including chronic pelvic pain and painful intercourse
• Emotional distress and loss of enjoyment of life
• Out-of-pocket expenses such as travel for specialty care and medical equipment
• Loss of consortium or relationship harms in applicable cases

TorHoerman Law: Investigating Ethicon Vaginal Mesh Lawsuits

TorHoerman Law is investigating claims involving Ethicon vaginal mesh devices and the serious complications some women report after transvaginal implantation.

A focused case review looks at what product was used, how symptoms developed, what treatment was required, and whether the medical record supports a clear connection between the device and the injuries.

If you are dealing with ongoing pelvic pain, erosion, infection, urinary problems, or repeat procedures after a mesh implant, a conversation with a transvaginal mesh lawyer can help clarify whether the facts support an individual lawsuit.

Contact TorHoerman Law to discuss your history and learn what records may be needed to evaluate your claim.

You can also use the chat feature on this page to find out if you qualify for an Ethicon vaginal mesh lawsuit.